FRANCESCA RAMOS: Open Payments
NPI 1184149114 · WEST BABYLON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,087 in 158 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,317 · 2025 $4,087
Food & beverage: $3,975Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $561 |
| Teva Pharmaceuticals USA, Inc. | 21 | $520 |
| Vanda Pharmaceuticals Inc. | 19 | $494 |
| Neurocrine BioSciences, Inc. | 22 | $477 |
| Axsome Therapeutics, Inc. | 10 | $414 |
| Otsuka America Pharmaceutical, Inc. | 15 | $413 |
| E.R. Squibb & Sons, L.L.C. | 13 | $406 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $277 |
| Lundbeck LLC | 10 | $205 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
Products named: INGREZZA, Auvelity, COBENFY, REXULTI, ARISTADA, FANAPT, CAPLYTA, UZEDY.
Industry payments across NY — which companies pay providers there.
